Iron infusion and depostiion in the kidney

Clinical Nephrology

Volumn 79, Issue 3, 2013, Pages 237-240

  Tolouian, Ramin ^a   Rajabi, Babak ^a   Boman, Darius ^b   Bilbao, Jorge ^b   Gupta, Ajay ^c  

^a Division of Nephrology   (United States)

^b Paul L Foster School of Medicine   (United States)

^c Rockwell Medical   (United States)

Author keywords

Ferumoxytol; Iron depostiion; Iron dextran; Iron infusion; Renal depostiion

Indexed keywords

CARBOHYDRATE; FERUMOXYTOL; IRON DEXTRAN; IRON;

ADULT; ARTICLE; CASE REPORT; CHRONIC KIDNEY DISEASE; COMPLEX FORMATION; DRUG INFUSION; HISTIOCYTE; HUMAN; HUMAN TISSUE; IRON DEFICIENCY ANEMIA; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY INTERSTITIUM; MACROPHAGE; MALE; MEDICAL RECORD REVIEW; MOLECULAR WEIGHT; NEPHROTIC SYNDROME; OXIDATIVE STRESS; RETICULOENDOTHELIAL SYSTEM; RETROSPECTIVE STUDY; STAINING; AGED; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; HUMANS; INFUSIONS, INTRAVENOUS; IRON; KIDNEY; MALE; MIDDLE AGED; OXIDATIVE STRESS;

MLCS; MLOWN;

EID: 84874973230     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN107361     Document Type: Article

References (18)

1. Kalantar-Zadeh K, McAllister CJ, Lehn RS, Liu E, Kopple JD. A low serum iron level is a predictor of poor outcome in hemodialysis patients. Am J Kidney Dis. 2004; 43: 671-684. doi:10.1053/j. ajkd.2003.12.029 PubMed
2. Hörl WH. Clinical aspects of iron use in the anemia of kidney disease. J Am Soc Nephrol. 2007; 18: 382-393. doi:10.1681/ASN.2006080856 Pub Med
3. Zager RA. Parenteral iron treatment induces MCP-1 accumulation in plasma, normal kidneys, and in experimental nephropathy. Kidney Int. 2005; 68: 1533-1542. doi:10.1111/j.1523-1755.20 05.0 056 5.x PubMed
4. Agarwal R, Vasavada N, Sachs NG, Chase S. Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease. Kidney Int. 2004; 65: 2279-2289. doi:10.111 1/j.1523- 1755.2004.00648.x PubMed
5. Bishu K, Agarwal R. Acute injury with intravenous iron and concerns regarding long-term safety. Clin J Am Soc Nephrol. 2006; 1 (Suppl 1): S19-S23. doi:10.2215/CJN.01420406 PubMed
6. Agarwal R. Ironing out the mystery of nephrotoxicity of parenteral iron. J Lab Clin Med. 2005; 146: 5-6. doi:10.1016/j.lab.2005.03.015 PubMed
7. Agarwal R, Warnock D. Issues related to iron replacement in chronic kidney disease. Semin Nephrol. 2002; 22: 479-487. PubMed
8. Agarwal R, Leehey DJ, Olsen SM, Dahl NV. Proteinuria induced by parenteral iron in chronic kidney disease-a comparative randomized controlled trial. Clin J Am Soc Nephrol. 2011; 6: 114-121. doi:10.2215/CJN.06020710 PubMed
9. Leehey DJ, Palubiak DJ, Chebrolu S, Agarwal R. Sodium ferric gluconate causes oxidative stress but not acute renal injury in patients with chronic kidney disease: a pilot study. Nephrol Dial Transplant. 2005; 20: 135-140. doi:10.1093/ndt/gfh565 PubMed
10. Agarwal R. Proinflammatory effects of iron sucrose in chronic kidney disease. Kidney Int. 2006; 69: 1259-1263. doi:10.1038/sj.ki.5000164 PubMed
11. Mazza J, Barr RM, McDonald JW, Valberg LS. Usefulness of the serum ferritin concentration in the detection of iron deficiency in a general hospital. Can Med Assoc J. 1978; 119: 884-886. PubMed
12. Wulfhekel U, Düllmann J. The diagnostic value of bone marrow iron. Folia Haematol Int Mag Klin Morphol Blutforsch. 1990; 117: 419-434. PubMed
13. Thomason RW, Lavelle J, Nelson D, Lin K, Uherova P. Parenteral iron therapy is associated with a characteristic pattern of iron staining on bone marrow aspirate smears. Am J Clin Pathol. 2007; 128: 590-593. doi:10.1309/WEDK7D1P7YPT- 8G0F PubMed
14. Islam MS, Anoop P. Characteristic distribution of iron in the bone marrow after parenteral iron therapy. Int J Lab Hematol. 2011; 33: 109.
15. Wang H, Nishiya K, Ito H, Hosokawa T, Hashimoto K, Moriki T. Iron depostiion in renal biopsy specimens from patients with kidney diseases. Am J Kidney Dis. 2001; 38: 1038-1044. doi:10 .1053/ajkd.2001.28593 PubMed
16. Lu M, Cohen MH, Rieves D, Pazdur R. FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease. Am J Hematol. 2010; 85: 315-319. PubMed
17. Knutson M, Wessling-Resnick M. Iron metabolism in the reticuloendothelial system. Crit Rev Biochem Mol Biol. 2003; 38: 61-88. doi:10.1080/713609210 PubMed
18. Zager RA, Johnson AC, Hanson SY. Parenteral iron nephrotoxicity: potential mechanisms and consequences. Kidney Int. 2004; 66: 144-156. doi:10.1111/j.1523-1755.2004.00716.x PubMed